Cargando…
The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to Maternal ABO Genotypes
Background. Maternal alloantibodies against HPA-1a can cross placenta, opsonize foetal platelets, and induce neonatal alloimmune thrombocytopenia (NAIT). In a study of 100, 448 pregnant women in Norway during 1995–2004, 10.6% of HPA-1a negative women had detectable anti-HPA-1a antibodies. Design and...
Autores principales: | Ahlen, Maria Therese, Husebekk, Anne, Killie, Mette Kjær, Kjeldsen-Kragh, Jens, Olsson, Martin L., Skogen, Bjørn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216343/ https://www.ncbi.nlm.nih.gov/pubmed/22110529 http://dx.doi.org/10.1155/2012/156867 |
Ejemplares similares
-
Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities
por: Tiller, Heidi, et al.
Publicado: (2017) -
Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
por: Weng, Ying-Jan, et al.
Publicado: (2016) -
Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study
por: Kjær, Mette, et al.
Publicado: (2017) -
ABO incompatibility: A cause for neonatal alloimmune thrombocytopenia
por: Shah, Ripal J., et al.
Publicado: (2023) -
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention
por: Brojer, Ewa, et al.
Publicado: (2015)